Recent Price Movements and Market Context
On 20 Jan 2026, Kronox Lab Sciences Ltd’s shares closed at Rs.125.6, hitting both a 52-week and all-time low. The stock recorded a day’s decline of 2.84%, underperforming the Sensex which fell by 0.42% on the same day. Intraday, the share price touched a low of Rs.125.6, down 2.37% from the previous close. This marks the fourth consecutive day of losses, with the stock declining by 4.96% over this period.
The stock’s performance has lagged considerably over multiple time horizons. Over the past week, it has fallen 5.41% compared to the Sensex’s 0.87% decline. The one-month return stands at -12.71%, significantly worse than the Sensex’s -2.39%. Over three months, the stock has dropped 19.02%, while the Sensex declined by only 1.74%. The year-to-date performance shows a 10.10% loss against the Sensex’s 2.72% fall.
Longer-term figures reveal a stark contrast with the broader market. Over the last year, Kronox Lab Sciences Ltd’s shares have depreciated by 32.38%, whereas the Sensex has appreciated by 7.56%. The stock has also failed to generate any returns over three, five, and ten-year periods, remaining flat at 0.00%, while the Sensex has delivered gains of 36.75%, 66.49%, and 244.52% respectively.
Technically, the stock is trading below all key moving averages including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish trend.
Momentum building strong! This Mid Cap from NBFC is on our MomentumNow radar. Other investors are catching on – will you join?
- - Building momentum strength
- - Investor interest growing
- - Limited time advantage
Financial Performance and Valuation Metrics
Kronox Lab Sciences Ltd operates within the Specialty Chemicals industry and has exhibited subdued growth over the medium term. Net sales have expanded at an annualised rate of 6.80% over the past five years, reflecting modest top-line progression. The company reported flat results in the quarter ending September 2025, indicating limited momentum in recent earnings.
Despite the stock’s negative price trajectory, the company’s profitability has shown some improvement, with profits rising by 19% over the past year. However, this has not translated into positive returns for shareholders, as the share price has declined sharply during the same period.
Return on equity (ROE) stands at a robust 28.6%, yet the valuation appears stretched with a price-to-book (P/B) ratio of 5.3, suggesting the market is pricing in high expectations despite the recent price weakness.
The company maintains a conservative capital structure, with an average debt-to-equity ratio of zero, indicating no reliance on debt financing. Promoters remain the majority shareholders, maintaining control over the company’s strategic direction.
Comparative Performance and Market Standing
When benchmarked against the BSE500 index, Kronox Lab Sciences Ltd has underperformed consistently over the last three years, one year, and three months. This underperformance highlights challenges in sustaining competitive growth and market valuation relative to a broad basket of listed companies.
The company’s Mojo Score currently stands at 30.0, reflecting a cautious market stance. Its Mojo Grade was downgraded from Hold to Sell on 7 Oct 2025, signalling a reassessment of the stock’s outlook by rating agencies. The market capitalisation grade is rated at 4, indicating a relatively small market cap within its sector.
Why settle for Kronox Lab Sciences Ltd? SwitchER evaluates this Specialty Chemicals micro-cap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Summary of Key Indicators
The stock’s recent performance metrics underscore a challenging environment for Kronox Lab Sciences Ltd. The persistent decline over multiple time frames, combined with a valuation that appears elevated relative to earnings growth, paints a complex picture. While profitability metrics such as ROE remain strong, the lack of share price appreciation over extended periods contrasts sharply with broader market gains.
Trading below all major moving averages and registering new lows, the stock’s technical indicators align with the fundamental data pointing to subdued investor sentiment and market confidence.
With promoter ownership intact and a debt-free balance sheet, the company’s capital structure remains stable, though this has not been sufficient to arrest the downward price trend.
Overall, Kronox Lab Sciences Ltd’s stock performance reflects a combination of modest sales growth, flat recent results, and valuation concerns, contributing to its current position at an all-time low.
Unlock special upgrade rates for a limited period. Start Saving Now →
